307 related articles for article (PubMed ID: 18684091)
1. Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass.
Kamiya N; Ye L; Kobayashi T; Lucas DJ; Mochida Y; Yamauchi M; Kronenberg HM; Feng JQ; Mishina Y
J Bone Miner Res; 2008 Dec; 23(12):2007-17. PubMed ID: 18684091
[TBL] [Abstract][Full Text] [Related]
2. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
[TBL] [Abstract][Full Text] [Related]
3. BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway.
Kamiya N; Ye L; Kobayashi T; Mochida Y; Yamauchi M; Kronenberg HM; Feng JQ; Mishina Y
Development; 2008 Nov; 135(22):3801-11. PubMed ID: 18927151
[TBL] [Abstract][Full Text] [Related]
4. Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts.
Kamiya N; Kobayashi T; Mochida Y; Yu PB; Yamauchi M; Kronenberg HM; Mishina Y
J Bone Miner Res; 2010 Feb; 25(2):200-10. PubMed ID: 19874086
[TBL] [Abstract][Full Text] [Related]
5. Controversy of physiological vs. pharmacological effects of BMP signaling: Constitutive activation of BMP type IA receptor-dependent signaling in osteoblast lineage enhances bone formation and resorption, not affecting net bone mass.
Kamiya N; Atsawasuwan P; Joiner DM; Waldorff EI; Goldstein S; Yamauchi M; Mishina Y
Bone; 2020 Sep; 138():115513. PubMed ID: 32603910
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
7. Conditional deletion of Bmpr1a in differentiated osteoclasts increases osteoblastic bone formation, increasing volume of remodeling bone in mice.
Okamoto M; Murai J; Imai Y; Ikegami D; Kamiya N; Kato S; Mishina Y; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2011 Oct; 26(10):2511-22. PubMed ID: 21786321
[TBL] [Abstract][Full Text] [Related]
8. Osteoblasts provide a suitable microenvironment for the action of receptor activator of nuclear factor-kappaB ligand.
Yamamoto Y; Udagawa N; Matsuura S; Nakamichi Y; Horiuchi H; Hosoya A; Nakamura M; Ozawa H; Takaoka K; Penninger JM; Noguchi T; Takahashi N
Endocrinology; 2006 Jul; 147(7):3366-74. PubMed ID: 16627581
[TBL] [Abstract][Full Text] [Related]
9. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
10. BMPRIA is required for osteogenic differentiation and RANKL expression in adult bone marrow mesenchymal stromal cells.
Biswas S; Li P; Wu H; Shafiquzzaman M; Murakami S; Schneider MD; Mishina Y; Li B; Li J
Sci Rep; 2018 May; 8(1):8475. PubMed ID: 29855498
[TBL] [Abstract][Full Text] [Related]
11. Disruption of bone morphogenetic protein type IA receptor in osteoblasts impairs bone quality and bone strength in mice.
Bao Q; Li A; Chen S; Feng J; Liu H; Qin H; Li J; Liu D; Shen Y; Zong Z
Cell Tissue Res; 2018 Nov; 374(2):263-273. PubMed ID: 29987355
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling.
Mishina Y; Starbuck MW; Gentile MA; Fukuda T; Kasparcova V; Seedor JG; Hanks MC; Amling M; Pinero GJ; Harada S; Behringer RR
J Biol Chem; 2004 Jun; 279(26):27560-6. PubMed ID: 15090551
[TBL] [Abstract][Full Text] [Related]
13. Loss of BMP signaling through BMPR1A in osteoblasts leads to greater collagen cross-link maturation and material-level mechanical properties in mouse femoral trabecular compartments.
Zhang Y; McNerny EG; Terajima M; Raghavan M; Romanowicz G; Zhang Z; Zhang H; Kamiya N; Tantillo M; Zhu P; Scott GJ; Ray MK; Lynch M; Ma PX; Morris MD; Yamauchi M; Kohn DH; Mishina Y
Bone; 2016 Jul; 88():74-84. PubMed ID: 27113526
[TBL] [Abstract][Full Text] [Related]
14. The Role Of BMPs in the Regulation of Osteoclasts Resorption and Bone Remodeling: From Experimental Models to Clinical Applications.
Bordukalo-Nikšić T; Kufner V; Vukičević S
Front Immunol; 2022; 13():869422. PubMed ID: 35558080
[TBL] [Abstract][Full Text] [Related]
15. BMP-induced Atoh8 attenuates osteoclastogenesis by suppressing Runx2 transcriptional activity and reducing the Rankl/Opg expression ratio in osteoblasts.
Yahiro Y; Maeda S; Morikawa M; Koinuma D; Jokoji G; Ijuin T; Komiya S; Kageyama R; Miyazono K; Taniguchi N
Bone Res; 2020; 8(1):32. PubMed ID: 32923015
[TBL] [Abstract][Full Text] [Related]
16. Mechanical Loading Synergistically Increases Trabecular Bone Volume and Improves Mechanical Properties in the Mouse when BMP Signaling Is Specifically Ablated in Osteoblasts.
Iura A; McNerny EG; Zhang Y; Kamiya N; Tantillo M; Lynch M; Kohn DH; Mishina Y
PLoS One; 2015; 10(10):e0141345. PubMed ID: 26489086
[TBL] [Abstract][Full Text] [Related]
17. New insights on the roles of BMP signaling in bone-A review of recent mouse genetic studies.
Kamiya N; Mishina Y
Biofactors; 2011; 37(2):75-82. PubMed ID: 21488130
[TBL] [Abstract][Full Text] [Related]
18. Thrombin receptor deficiency leads to a high bone mass phenotype by decreasing the RANKL/OPG ratio.
Tudpor K; van der Eerden BC; Jongwattanapisan P; Roelofs JJ; van Leeuwen JP; Bindels RJ; Hoenderop JG
Bone; 2015 Mar; 72():14-22. PubMed ID: 25460576
[TBL] [Abstract][Full Text] [Related]
19. The role of BMPs in bone anabolism and their potential targets SOST and DKK1.
Kamiya N
Curr Mol Pharmacol; 2012 Jun; 5(2):153-63. PubMed ID: 21787290
[TBL] [Abstract][Full Text] [Related]
20. Overloaded Orthopedic Force Induces Condylar Subchondral Bone Absorption by Stimulating Rat Mesenchymal Stem Cells Differentiating into Osteoclasts via mTOR-Regulated
Tian Y; Chen J; Yan X; Ren D; Liu M; Zhang Q; Zhang Q; Yuan X
Stem Cells Dev; 2021 Jan; 30(1):29-38. PubMed ID: 33176606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
